?Cancer Research Career Enhancement and Related Activities A strategic goal for the SJCCC is to develop a well-trained, diverse biomedical workforce through research education, training, and career-development activities that promote understanding of the biology and treatment of childhood cancer. Research shows that early intervention strategies, beginning in elementary and middle school, are essential to enhancing the biomedical careers pipeline, especially for students from underrepresented backgrounds. The SJCCC provides the financial support, leadership and institutional infrastructure to support this comprehensive biomedical training pipeline, initiating efforts in elementary school and continuing through the faculty level. Career enhancement activities are led by the Associate Director for Education and Training, Dr. Gerard Zambetti, who also serves as an institutional Vice President and Director of the Academic Programs Office in Biomedical Sciences, allowing a seamless integration of SJCCC and institutional efforts. Dr. Zambetti coordinates the efforts of a qualified group of staff supporting elementary education and outreach, pre- and postdoctoral education and training, and faculty career development activities. He also works closely with the Center Director, Senior Leadership and Program Leaders to develop, evaluate and oversee an extensive portfolio of career enhancement activities across this spectrum. For example, the SJCCC Cancer Education and Outreach Program has worked with thousands of K-5 students and teachers, particularly in underrepresented communities, to inspire pursuit of research careers, and our NCI-funded Pediatric Oncology Education Program has trained more than 1200 students, 23% of whom are underrepresented minorities and 87% of whom have gone on to receive doctoral degrees. Dr. Zambetti and SJCCC members were also instrumental in the development and launch of the St. Jude Graduate School in Biomedical Sciences, a new PhD program focused on translational research that matriculated its first class of 12 students in 2017. The SJCCC also launched the annual Science Scholars of Tomorrow Symposium to provide high school students and teachers insight into cutting-edge pediatric cancer research and the Clinical Shadowing Program for postdoctoral fellows to develop experience in how laboratory research relates to the treatment and care of pediatric cancer patients. In addition, the Center initiated new grant-writing workshops for postdoctoral fellows and faculty to support development of their research careers. Future plans for the next project period include the continued growth and accreditation of the St. Jude Graduate School, the addition of a new Masters program in Global Health, establishment of a certificate-based program for physicians and healthcare providers (St. Jude Global Academy), expansion of our K-12 educational efforts, and a focused initiative to expand NIH/NCI-funded training and educational programs (e.g., R25, T32, K awards) for students and fellows.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA021765-41
Application #
9883736
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-03-01
Budget End
2021-02-28
Support Year
41
Fiscal Year
2020
Total Cost
Indirect Cost
Name
St. Jude Children's Research Hospital
Department
Type
DUNS #
067717892
City
Memphis
State
TN
Country
United States
Zip Code
38105
van Oosterwijk, Jolieke G; Buelow, Daelynn R; Drenberg, Christina D et al. (2018) Hypoxia-induced upregulation of BMX kinase mediates therapeutic resistance in acute myeloid leukemia. J Clin Invest 128:369-380
Howell, Carrie R; Wilson, Carmen L; Ehrhardt, Matthew J et al. (2018) Clinical impact of sedentary behaviors in adult survivors of acute lymphoblastic leukemia: A report from the St. Jude Lifetime Cohort study. Cancer 124:1036-1043
Zamora, Anthony E; Crawford, Jeremy Chase; Thomas, Paul G (2018) Hitting the Target: How T Cells Detect and Eliminate Tumors. J Immunol 200:392-399
Zhong, Bo; Maharaj, Anil; Davis, Abigail et al. (2018) Development and validation of a sensitive LC MS/MS method for the measurement of the checkpoint kinase 1 inhibitor prexasertib and its application in a cerebral microdialysis study. J Pharm Biomed Anal 156:97-103
Upadhyaya, Santhosh A; Robinson, Giles W; Harreld, Julie H et al. (2018) Marked functional recovery and imaging response of refractory optic pathway glioma to BRAFV600E inhibitor therapy: a report of two cases. Childs Nerv Syst 34:605-610
Goldsby, Robert E; Stratton, Kayla L; Raber, Shannon et al. (2018) Long-term sequelae in survivors of childhood leukemia with Down syndrome: A childhood cancer survivor study report. Cancer 124:617-625
Howell, Carrie R; Krull, Kevin R; Partin, Robyn E et al. (2018) Randomized web-based physical activity intervention in adolescent survivors of childhood cancer. Pediatr Blood Cancer 65:e27216
Cherian, Milu T; Chai, Sergio C; Wright, William C et al. (2018) CINPA1 binds directly to constitutive androstane receptor and inhibits its activity. Biochem Pharmacol 152:211-223
Hoehn, Mary Ellen; Calderwood, Julie; Gannon, Edwin et al. (2018) Ocular complications in a young pediatric population following bone marrow transplantation. J AAPOS 22:102-106.e1
Devine, Katie A; Mertens, Ann C; Whitton, John A et al. (2018) Factors associated with physical activity among adolescent and young adult survivors of early childhood cancer: A report from the childhood cancer survivor study (CCSS). Psychooncology 27:613-619

Showing the most recent 10 out of 6764 publications